Allergan is still on the acquisition trail following its failed merger with Pfizer, spending $85 million to acquire privately-held Topokine Therapeutics and its late-stage product for under-eye bags.

Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan ...

On Tuesday, pharmaceutical giant AbbVie said it's acquiring Allergan, the company that makes Botox. Initially found to be a treatment for a tight eyelid condition, doctors started realizing that ...

A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9, a technology that allows genes to be manipulated inside the body. The two companies claim AGN ...

general manager and vice president at Allergan Women's Healthcare. "ActuallySheCan is an unbranded program that helps millennial women achieve all their goals, personal, professional, health and ...

The agreement between the companies—in which Allergan would technically be the buyer—appears more of an attempt to dodge newly minted federal tax rules than a push to ramp up innovation. Allergan’s ...